Free Trial

MetLife, Inc. (NYSE:MET) Receives Consensus Rating of "Buy" from Brokerages

MetLife logo with Finance background

Shares of MetLife, Inc. (NYSE:MET - Get Free Report) have been assigned a consensus rating of "Buy" from the thirteen analysts that are covering the firm, MarketBeat reports. Thirteen analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have covered the stock in the last year is $88.46.

Several research analysts have recently weighed in on MET shares. StockNews.com raised MetLife from a "hold" rating to a "buy" rating in a research report on Tuesday. Wells Fargo & Company boosted their target price on shares of MetLife from $92.00 to $93.00 and gave the stock an "overweight" rating in a research note on Tuesday, November 5th. Barclays lowered their target price on MetLife from $91.00 to $90.00 and set an "overweight" rating for the company in a report on Thursday, October 31st. Bank of America cut their price target on MetLife from $99.00 to $96.00 and set a "buy" rating on the stock in a research note on Thursday, August 1st. Finally, Jefferies Financial Group raised their price objective on shares of MetLife from $89.00 to $95.00 and gave the company a "buy" rating in a report on Friday, September 27th.

View Our Latest Analysis on MetLife

Institutional Investors Weigh In On MetLife

Several large investors have recently added to or reduced their stakes in the company. MeadowBrook Investment Advisors LLC grew its position in shares of MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. raised its stake in MetLife by 131.9% in the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock valued at $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC grew its position in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider's stock valued at $29,000 after acquiring an additional 277 shares during the last quarter. Peterson Financial Group Inc. purchased a new position in MetLife in the 3rd quarter worth $30,000. Finally, Fortitude Family Office LLC increased its holdings in shares of MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider's stock worth $34,000 after buying an additional 266 shares during the period. Hedge funds and other institutional investors own 89.81% of the company's stock.

MetLife Stock Up 0.7 %

MET traded up $0.58 during trading on Thursday, reaching $82.60. The company had a trading volume of 2,702,770 shares, compared to its average volume of 3,325,695. The company has a market cap of $57.19 billion, a P/E ratio of 16.54, a PEG ratio of 0.75 and a beta of 1.05. MetLife has a 12 month low of $61.61 and a 12 month high of $86.94. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The business's fifty day moving average price is $81.30 and its 200 day moving average price is $75.43.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be given a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 2.64%. The ex-dividend date is Tuesday, November 5th. MetLife's dividend payout ratio (DPR) is 43.95%.

MetLife Company Profile

(Get Free Report

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Recommended Stories

Analyst Recommendations for MetLife (NYSE:MET)

Should you invest $1,000 in MetLife right now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines